Health Minister Musab al-Ali said in a meeting with Damascus Industry Chamber on Wednesday that developing pharmaceutical industries is a key pillar of the ministry’s plan, stressing the need to maintain pharmaceutical security —particularly for patients suffering from multiple sclerosis, cancers, and autoimmune diseases, who face shortages of specialized medications.
Al-Ali underlined the importance of bridging the gap between local needs and actual market supply, calling for faster registration of pharmaceutical products and the establishment of new factories specialized in medical devices and consumables.
He also urged a re-evaluation of existing plants to improve efficiency and quality standards.
While Mohammad Ayman al-Moulawi, head of the Damascus and Countryside Chamber of Industry affirmed the Chamber’s commitment to developing Syria’s pharmaceutical sector, noting that closer coordination between the ministry and manufacturers could streamline procedures, enhance competitiveness, and better serve national health objectives.
The meeting was attended by the Deputy Minister for Pharmaceutical Affairs, representatives of the Departments of Supply, Pharmaceutical Affairs, Laboratories and pharmaceutical Control, and several senior officials.
According to the ministry, the discussions come within ongoing national efforts to support the domestic pharmaceutical industry and reduce shortages in vital medicines, especially those used for chronic and immune-related illnesses.
